Status:
ACTIVE_NOT_RECRUITING
Xerosis and Use of Topical Moisturizer
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
Galderma R&D
Conditions:
Xerosis Due to Atopic Dermatitis
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The primary hypothesis is that routine measurement of trans epidermal water loss (TEWL) rates and stratum corneum (SC) hydration levels will promote patient adherence to maintenance moisturizer therap...
Detailed Description
Adult subjects will be offered an opportunity to participate in the study. Subjects will have a diagnosis of xerosis in the context (current or historic) of atopic dermatitis. A total of 30 subjects w...
Eligibility Criteria
Inclusion
- Subject is 18 years of age or older.
- Subject has a working knowledge of English.
- Subject with a diagnosis of xerosis in the context (current or historic) of atopic dermatitis
Exclusion
- Subjects under 18 years of age.
- Subject does not have a working knowledge of English.
Key Trial Info
Start Date :
January 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2026
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04341623
Start Date
January 21 2021
End Date
August 1 2026
Last Update
December 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Health Sciences Department of Dermatology
Winston-Salem, North Carolina, United States, 27157